Benitec Biopharma (BNTC) News Today $9.40 +0.27 (+2.96%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 24 at 7:20 AM | americanbankingnews.comBenitec Biopharma Inc. (NASDAQ:BNTC) to Post FY2024 Earnings of ($5.45) Per Share, Leerink Partnrs ForecastsJuly 24 at 6:13 AM | marketbeat.comBenitec Biopharma Inc. to Post FY2024 Earnings of ($5.45) Per Share, Leerink Partnrs Forecasts (NASDAQ:BNTC)Benitec Biopharma Inc. (NASDAQ:BNTC - Free Report) - Leerink Partnrs issued their FY2024 earnings estimates for Benitec Biopharma in a research report issued on Monday, July 22nd. Leerink Partnrs analyst M. Foroohar forecasts that the biotechnology company will post earnings of ($5.45) per shareJuly 23, 2024 | markets.businessinsider.comBuy Rating on Benitec Biopharma: Anticipating BB-301’s Impact on OPMD Treatment and Stock ValueJuly 23, 2024 | msn.comLeerink Partners Initiates Coverage of Benitec Biopharma (BNTC) with Outperform RecommendationJuly 23, 2024 | americanbankingnews.comBenitec Biopharma (NASDAQ:BNTC) Rating Increased to Strong-Buy at Leerink PartnrsJuly 22, 2024 | lse.co.ukBenitec Biopharma Share Price (BNTC.US)July 22, 2024 | americanbankingnews.comSVB Leerink Initiates Coverage on Benitec Biopharma (NASDAQ:BNTC)July 22, 2024 | marketbeat.comBenitec Biopharma (NASDAQ:BNTC) Now Covered by Analysts at SVB LeerinkSVB Leerink started coverage on shares of Benitec Biopharma in a research note on Monday. They set an "outperform" rating and a $13.00 price objective for the company.July 19, 2024 | investing.comBenitec Biopharma Ltd ADR (BNTC)July 19, 2024 | americanbankingnews.comBenitec Biopharma (NASDAQ:BNTC) Stock Price Crosses Above 50 Day Moving Average of $8.33July 15, 2024 | globenewswire.comBenitec Biopharma Reports Continued Durable Improvements in the Radiographic Assessments of Swallowing Efficiency and the Subject-Reported Outcome Instrument at the 180-Day Timepoint for First OPMD Subject Treated with Low-Dose BB-301 in Phase 1b/2a StudyJuly 11, 2024 | marketbeat.comShort Interest in Benitec Biopharma Inc. (NASDAQ:BNTC) Rises By 871.6%Benitec Biopharma Inc. (NASDAQ:BNTC - Get Free Report) saw a large growth in short interest in the month of June. As of June 30th, there was short interest totalling 92,300 shares, a growth of 871.6% from the June 15th total of 9,500 shares. Based on an average daily trading volume, of 97,700 shares, the short-interest ratio is presently 0.9 days. Approximately 4.1% of the company's stock are sold short.June 29, 2024 | marketbeat.comBenitec Biopharma Inc. (NASDAQ:BNTC) Sees Large Decrease in Short InterestBenitec Biopharma Inc. (NASDAQ:BNTC - Get Free Report) was the target of a significant decline in short interest during the month of June. As of June 15th, there was short interest totalling 9,500 shares, a decline of 25.8% from the May 31st total of 12,800 shares. Based on an average trading volume of 96,100 shares, the short-interest ratio is presently 0.1 days. Currently, 0.4% of the company's shares are short sold.June 29, 2024 | marketbeat.comBenitec Biopharma (NASDAQ:BNTC) Stock Passes Below 50 Day Moving Average of $7.93Benitec Biopharma (NASDAQ:BNTC) Stock Price Crosses Below 50 Day Moving Average of $7.93June 21, 2024 | marketbeat.comBenitec Biopharma (NASDAQ:BNTC) Share Price Passes Below Fifty Day Moving Average of $7.76Benitec Biopharma (NASDAQ:BNTC) Share Price Crosses Below Fifty Day Moving Average of $7.76June 6, 2024 | marketbeat.comBenitec Biopharma (NASDAQ:BNTC) Shares Pass Below 50 Day Moving Average of $7.34Benitec Biopharma (NASDAQ:BNTC) Stock Passes Below 50 Day Moving Average of $7.34May 29, 2024 | marketbeat.comBenitec Biopharma Inc. (NASDAQ:BNTC) Sees Large Decline in Short InterestBenitec Biopharma Inc. (NASDAQ:BNTC - Get Free Report) was the recipient of a significant decline in short interest in May. As of May 15th, there was short interest totalling 56,100 shares, a decline of 43.0% from the April 30th total of 98,500 shares. Based on an average trading volume of 87,400 shares, the days-to-cover ratio is currently 0.6 days. Approximately 2.5% of the company's stock are short sold.May 20, 2024 | markets.businessinsider.comBuy Rating for Benitec Biopharma on Promising Early-Stage Clinical Data and Solid FinancialsMay 18, 2024 | marketbeat.comBenitec Biopharma (NASDAQ:BNTC) Shares Cross Above 50 Day Moving Average of $6.50Benitec Biopharma (NASDAQ:BNTC) Stock Price Crosses Above Fifty Day Moving Average of $6.50May 13, 2024 | finance.yahoo.comBenitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational UpdateMay 13, 2024 | investorplace.comBNTC Stock Earnings: Benitec Biopharma Misses EPS for Q3 2024May 1, 2024 | finance.yahoo.comBenitec Biopharma to Participate in the Citizens JMP Life Science ConferenceApril 18, 2024 | msn.comWhy Is Gene Therapy Developer Benitec Biopharma Stock Trading Higher On Thursday?April 18, 2024 | marketbeat.comTrading was temporarily halted for "BNTC" at 09:04 AM with a stated reason of "LULD pause." Trading set to resume at 10:04 AM. April 18, 2024 | marketbeat.comTrading was temporarily halted for "BNTC" at 09:04 AM with a stated reason of "LULD pause."April 18, 2024 | finanznachrichten.deBenitec Biopharma Inc.: Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a StudyApril 18, 2024 | msn.comBenitec Biopharma jumps 33% on $40M private financingApril 18, 2024 | markets.businessinsider.comWhy Benitec Biopharma Is Rising In Pre-market?April 18, 2024 | globenewswire.comBenitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a StudyApril 18, 2024 | globenewswire.comBenitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 MillionApril 9, 2024 | finance.yahoo.comBenitec Biopharma to Host Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy on April 18, 2024March 24, 2024 | insidermonkey.com11 Best ASX Stocks To Buy NowFebruary 25, 2024 | msn.comBenitec Biopharma (BNTC) Price Target Increased by 66.67% to 10.20February 13, 2024 | finance.yahoo.comBenitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational UpdateNovember 30, 2023 | finance.yahoo.comHere's Why Benitec Biopharma Inc.'s (NASDAQ:BNTC) CEO Compensation Is The Least Of Shareholders ConcernsNovember 30, 2023 | finance.yahoo.comBenitec Biopharma Announces First Subject Dosed in Phase 1b/2a Clinical Trial for Gene Therapy Candidate BB-301 for the Treatment of Oculopharyngeal Muscular DystrophyNovember 19, 2023 | morningstar.comBenitec Biopharma Inc BNTCNovember 17, 2023 | finance.yahoo.comBenitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare ConferenceNovember 15, 2023 | finanznachrichten.deBenitec Biopharma Inc.: Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational UpdateNovember 14, 2023 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Benitec Biopharma (BNTC), Rezolute (RZLT)November 13, 2023 | finance.yahoo.comBenitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational UpdateSeptember 27, 2023 | msn.comJMP Securities Maintains Benitec Biopharma (BNTC) Market Outperform RecommendationSeptember 26, 2023 | markets.businessinsider.comJMP Securities Sticks to Its Buy Rating for Benitec Biopharma (BNTC)September 21, 2023 | finance.yahoo.comBenitec Biopharma Releases Full Year 2023 Financial Results and Provides Operational UpdateAugust 21, 2023 | finance.yahoo.comCitadel Advisors LLC Acquires New Stake in Benitec Biopharma IncAugust 11, 2023 | finance.yahoo.comBenitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public OfferingAugust 9, 2023 | marketbeat.comTrading was temporarily halted for "BNTC" at 10:08 AM with a stated reason of "LULD pause." Trading set to resume at 10:08 AM. August 9, 2023 | marketbeat.comTrading was temporarily halted for "BNTC" at 10:08 AM with a stated reason of "LULD pause."August 9, 2023 | msn.comBenitec Biopharma prices $30M equity offeringAugust 9, 2023 | finance.yahoo.comBenitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public Offering Get Benitec Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTC and its competitors with MarketBeat's FREE daily newsletter. Email Address We just added a $300 account credit to your MarketBeat subscription (Ad)MarketBeat All Access is our complete suite of portfolio monitoring software, research tools, stock screeners, proprietary reports, and more. Upgrade today and get $300 off your 2024-2025 subscription. Free for 30 days. Start Your Risk-Free Trial Here BNTC Media Mentions By Week BNTC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BNTC News Sentiment▼0.880.62▲Average Medical News Sentiment BNTC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BNTC Articles This Week▼151▲BNTC Articles Average Week Get Benitec Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ACIU News KMDA News INZY News NKTX News XOMA News AMRN News ALXO News MGNX News ENTA News AVIR News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BNTC) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Benitec Biopharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Benitec Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
